Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2695

Actual shortage: 246 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2440 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95378
TEVA-DUTASTERIDE 0.5MG CAPSULE Resolved 2019-10-03 2019-10-10 95370
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-10 68572
PORTIA 28 0.03MG 0.15MG TABLET Resolved 2019-09-26 2019-10-10 94874
PORTIA 21 0.03MG 0.15MG TABLET Resolved 2019-09-26 2019-10-10 94870
TEVA-LEVOCARBIDOPA 25MG 100MG TABLET Resolved 2019-09-26 2019-10-10 94864
TEVA-LACOSAMIDE 150MG TABLET Resolved 2019-10-03 2019-10-10 95387
PEMETREXED DISODIUM FOR INJECTION 500MG POWDER FOR SOLUTION Resolved 2019-09-05 2019-10-17 93140
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-04 2019-10-17 68569
ACT RIZATRIPTAN 10MG TABLET Resolved 2019-09-05 2019-10-17 93169
ACT LATANOPROST/TIMOLOL 5MG 50MCG SOLUTION Resolved 2019-08-22 2019-10-24 92229
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2019-08-22 2019-10-24 92180
APRI 28 0.15MG 0.03MG TABLET Resolved 2019-08-29 2019-10-24 92660
TEVA-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-08-29 2019-10-24 92666
TEVA-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Resolved 2019-08-29 2019-10-24 92669
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
RATIO-NYSTATIN 100000UNIT CREAM Resolved 2019-08-29 2019-10-26 92678
RATIO-NYSTATIN 100000UNIT CREAM Resolved 2019-08-29 2019-10-26 92681
TEVA-DEFERASIROX 500MG TABLET FOR SUSPENSION Resolved 2019-10-17 2019-10-26 96730
AVIANE 28 20MCG 100MCG TABLET Resolved 2019-09-26 2019-11-01 94828

Showing 401 to 420 of 2695

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT NABILONE 1MG CAPSULE Discontinued 2019-10-31 2019-11-01 97581
TEVA-DEFERASIROX 500MG TABLET FOR SUSPENSION Discontinued 2019-10-31 2019-11-01 97589
TEVA-PAROXETINE 30MG TABLET Discontinued 2019-12-09 2019-12-09 100540
TEVA-PAROXETINE 20MG TABLET Discontinued 2019-12-09 2019-12-09 100547
TEVA-ATENOLOL/CHLORTHALIDONE 25MG 100MG TABLET Discontinued 2020-01-21 2020-01-21 103781
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-DEFERASIROX 125MG TABLET FOR SUSPENSION Discontinued 2020-01-21 2020-01-21 103791
TEVA-DEFERASIROX 250MG TABLET FOR SUSPENSION Discontinued 2020-01-21 2020-01-21 103796
TEVA-LISINOPRIL (TYPE P) 20MG TABLET Discontinued 2020-01-24 2020-01-24 104257
TEVA-LAMIVUDINE/ZIDOVUDINE 300MG 150MG TABLET Discontinued 2020-01-24 2020-01-24 104260
TEVA-ARIPIPRAZOLE 5MG TABLET Discontinued 2020-01-24 2020-01-24 104263
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Discontinued 2020-01-24 2020-01-24 104277
TEVA-ARIPIPRAZOLE 5MG TABLET Discontinued 2020-01-24 2020-01-24 104283
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
TEVA-QUININE 300MG CAPSULE Discontinued 2020-01-24 2020-01-24 104294
TEVA-LEVETIRACETAM 500MG TABLET Discontinued 2020-01-24 2020-01-24 104304
TEVA-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-02-07 2020-02-08 105537
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2020-02-13 2020-02-13 106133
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139

Showing 141 to 160 of 250